CD206 + IL-4Rα + Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy
Circulation · 29.07.2025 · 152 (4) · 257-273
DOI: 10.1161/circulationaha.124.072411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 29.07.2025. Verfasst von Qiongxin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO (Q.W., M.A.I., Y.Z., G.R., T.H., S.D.P.). Hauptthemen laut MEDLINE: Macrophages, Ventricular Remodeling, Mannose-Binding Lectins, Receptors, Cell Surface. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: The role of cardiac CD (cluster of differentiation) 206 + macrophages in chronic heart failure (HF) is unknown. We examined whether CD206 + macrophages expressing IL (interleukin)–4Rα are key drivers of adverse left ventricular (LV) remodeling in HF. METHODS: Adult C57BL/6 mice underwent nonreperfused myocardial infarction to induce HF. Macrophages in murine and human hearts were profiled using flow cytometry and immunostaining. In vivo myeloid-specific IL-4Rα deletion and intramyocardial macrophage adoptive transfer defined the functional effects of macrophages polarized by IL-4 (M[IL-4]). Antisense oligonucleotides were used for in vivo IL-4Rα gene silencing in mice. RESULTS: CD206 + macrophages steadily expanded in hearts after myocardial infarction, such that at 8 weeks after myocardial infarction, they comprised ≈85% of all macrophages. These macrophages were proliferative, predominantly CCR2 – (C-C motif chemokine receptor) and MHC (major histocompatibility complex) II hi , and correlated with LV dysfunction and fibrosis. Nearly half of CD206 + macrophages expressed IL-4Rα, and the majority of CD206 + IL-4Rα + macrophages coexpressed profibrotic FIZZ (found in inflammatory zone) 1. Bone marrow–derived CD206 + M[IL-4] macrophages also exhibited marked upregulation of FIZZ1 and induced FIZZ1-dependent myofibroblast differentiation of both cardiac mesenchymal stem cells and cardiac fibroblasts, in part related to DLL (Delta-like ligand)-4/Jagged1-Notch1 signaling in cardiac mesenchymal stem cells. Intramyocardial adoptive transfer of M[IL-4], but not IL-10-polarized (M[IL-10]), CD206 + macrophages to naïve mice induced progressive LV remodeling over 4 weeks, increasing fibrosis, cardiomyocyte hypertrophy, and apoptosis. Myeloid-specific IL-4Rα gene deletion in HF (initiated 4 weeks after myocardial infarction) in IL-4Rα f/f LysM-Cre ERT2 mice significantly reduced CD206 + macrophage proliferation and effectively depleted CD206 + IL-4Rα + cardiac macrophages. This was associated with abrogation of LV remodeling progression, reduction of cardiac fibrosis, and improved neovascularization. In vivo IL-4Rα gene silencing in mice with established HF effectively depleted cardiac CD206 + IL-4Rα + macrophages and reversed LV remodeling, improving fibrosis, neovascularization, and dysfunction, and suppressed both local and systemic inflammation. Last, alternatively activated CD206 + and CD163 + macrophages were significantly expanded in human failing hearts and correlated with fibrosis. The majority of CD163 + macrophages expressed IL-4Rα and FIZZ3, the human homolog of FIZZ1. CONCLUSIONS: Cardiac CD206 + IL-4Rα + macrophages proliferate and expand in HF and are key mediators of pathological remodeling and fibrosis, in part through the secretion of FIZZ1. Inhibition of CD206 + macrophage IL-4Rα signaling alleviates LV remodeling in ischemic cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO (Q.W., M.A.I., Y.Z., G.R., T.H., S.D.P.).
- Department of Cardiology, Zhongnan Hospital of Wuhan University, China (Q.W.).
- Department of Medicine (Cardiovascular Disease), University of Alabama at Birmingham (Q.W., M.A.I., Y.Z., G.R., T.H., G.Z., S.M.P., S.D.P.).
ORCID-Profile: Mohamed Ameen Ismahil, Steven M Pogwizd, Sumanth D Prabhu
Förderung
- NHLBI NIH HHS
Zitieren
APA
Wang, Q., Ismahil, M. A., Zhu, Y., Rokosh, G., Hamid, T., Zhou, G., Pogwizd, S. M., & Prabhu, S. D. (2025). CD206 + IL-4Rα + Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy. Circulation, 152(4), 257-273. https://doi.org/10.1161/circulationaha.124.072411
Vancouver
Wang Q, Ismahil MA, Zhu Y, Rokosh G, Hamid T, Zhou G, et al. CD206 + IL-4Rα + Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy. Circulation. 2025;152(4):257-273. doi:10.1161/circulationaha.124.072411
BibTeX
@article{Wang2025,
author = {Wang, Qiongxin and Ismahil, Mohamed Ameen and Zhu, Yujie and Rokosh, Gregg and Hamid, Tariq and Zhou, Guihua and Pogwizd, Steven M and Prabhu, Sumanth D},
title = {CD206 + IL-4Rα + Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy},
journal = {Circulation},
year = {2025},
volume = {152},
number = {4},
pages = {257--273},
doi = {10.1161/circulationaha.124.072411}
}
EUVIMED